Project CFTR gene correction – Targeted gene correction of delF508 CFTR gene defect

Basic data

Acronym:
CFTR gene correction
Title:
Targeted gene correction of delF508 CFTR gene defect
Duration:
01/04/2016 to 31/03/2019
Abstract / short description:
This program will provide a novel technological platform for the safe and efficient in vivo gene correction of Cystic Fibrosis. By developing reagents in humanized models, all vectors will be directly translatable to future clinical trials.

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Paediatrics Department I and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Help

will be deleted permanently. This cannot be undone.